Lipopeptidomimetics derived from teixobactin have potent antibacterial activity against Staphylococcus aureus. (2018)

First Author: Girt GC
Attributed to:  Substrate Peptidomimetic Inhibitors (SPIs) of the COP9 signalosome funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/c7cc06093a

PubMed Identifier: 29484340

Publication URI: http://europepmc.org/abstract/MED/29484340

Type: Journal Article/Review

Volume: 54

Parent Publication: Chemical communications (Cambridge, England)

Issue: 22

ISSN: 1359-7345